Roche maintains obesity momentum, launches Phase II of injectable – FirstWord Pharma

Weightloss News
Roche maintains obesity momentum, launches Phase II of injectable. Top Storyweight loss of 18.8% at 24 weeks in a Phase I study. At the time …